Cetera Advisor Networks’s VanEck Pharmaceutical ETF PPH Stock Holding History

Cetera Advisor Networks’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.71M	Buy	18,836 +4,256	+29%	+$373K	0.01%	1114
2023 Q4	$1.19M	Buy	14,580 +5,151	+55%	+$404K	0.01%	1269
2023 Q3	$753K	Buy	9,429 +1,373	+17%	+$111K	﹤0.01%	1471
2023 Q2	$635K	Buy	8,056 +2,987	+59%	+$234K	﹤0.01%	1566
2023 Q1	$393K	Buy	5,069 +2,373	+88%	+$183K	﹤0.01%	1859
2022 Q4	$210K	Buy	+2,696	New	+$199K	﹤0.01%	2230
2020 Q3	–	Sell	-200	Closed	-$12K	–	2561
2020 Q2	$12K	Buy	+200	New	+$12.1K	﹤0.01%	2647

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Cetera Advisor Networks's PPH Position: Q1 2024 in Review

Cetera Advisor Networks increased its VanEck Pharmaceutical ETF (PPH) stake by 29% in Q1 2024, buying an estimated $373K and bringing the position to 18,836 shares worth $1.71M. The position accounts for 0.01% of the portfolio, ranked #1114.

Cetera Advisor Networks first reported a position in PPH in Q2 2020 and has held it in 7 quarters since. 138 funds tracked by Wall St. Rank hold PPH as of Q1 2024.

Cetera Advisor Networks held 18,836 shares of VanEck Pharmaceutical ETF worth $1.71M as of Q1 2024.
Cetera Advisor Networks bought 4,256 VanEck Pharmaceutical ETF shares in Q1 2024, an estimated $373K.
VanEck Pharmaceutical ETF made up 0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1114 holding.
Cetera Advisor Networks first reported a position in VanEck Pharmaceutical ETF in Q2 2020 and has held it in 7 quarters since.
138 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.